|
| Exchange Disseminated Time | Venus Remedies Ltd has informed BSE regarding "Venus Remedies to enter Japan market with patent approval for its novel research product 'Vancoplus'.
Announcement:
"The Company has achieved another landmark by fetching its first patent grant from Japan patent office (JPO) which is among the most stringent Pharma markets in the world. This patent has been granted for its novel research product 'Vancoplus' which has been designed to curb the growing bacterial resistance specially caused by the notorious MRSA strain which is usually termed as one of the Superbugs". (For more details kindly refer Corporate Announcements on www.bseindia.com). |
|
|